{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:05:48Z","timestamp":1781820348748,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["PON01_02418"],"award-info":[{"award-number":["PON01_02418"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["H2020-HEALTH - SC1-2017-RTD: \u201cSOLVE RD"],"award-info":[{"award-number":["H2020-HEALTH - SC1-2017-RTD: \u201cSOLVE RD"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s40618-020-01286-6","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T09:02:49Z","timestamp":1588928569000},"page":"165-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["BROX haploinsufficiency in familial nonmedullary thyroid cancer"],"prefix":"10.1007","volume":"44","author":[{"given":"D.","family":"Pasquali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Torella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Accardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Del Vecchio Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cantara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"1286_CR1","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.2018.0898","volume":"319","author":"C Durante","year":"2018","unstructured":"Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS (2018) The diagnosis and management of thyroid nodules: a review. JAMA 319:914\u2013924","journal-title":"JAMA"},{"key":"1286_CR2","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2017) SEER cancer statistics review, 1975\u20132014, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2014\/, based on November 2016 SEER data submission, posted to the SEER web site."},{"key":"1286_CR3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1001\/archsurg.1995.01430080094015","volume":"130","author":"RF Grossman","year":"1995","unstructured":"Grossman RF, Tu SH, Duh QY, Siperstein AE, Novosolov F, Clark OH (1995) Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 130:892\u2013897","journal-title":"Arch Surg"},{"key":"1286_CR4","first-page":"503","volume":"26","author":"KC Loh","year":"1997","unstructured":"Loh KC, Lo JC, Greenspan FS, Miller TR, Yeo PP (1997) Familial papillary thyroid cancer: a case report. Ann Acad Med Singapore 26:503\u2013506","journal-title":"Ann Acad Med Singapore"},{"key":"1286_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1067\/msy.2000.110848","volume":"128","author":"O Alsanea","year":"2000","unstructured":"Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PH, Treseler PA, Weier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH (2000) Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 128:1043\u20131050","journal-title":"Surgery"},{"key":"1286_CR6","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00268-002-6615-y","volume":"26","author":"S Uchino","year":"2002","unstructured":"Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, Shuto S (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26:897\u2013902","journal-title":"World J Surg"},{"key":"1286_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/jso.23447","volume":"109","author":"YM Lee","year":"2014","unstructured":"Lee YM, Yoon JH, Yi O, Tae-Yon Sung TY, Chung KW, Kim WB, Hong SJ (2014) Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. J Surg Oncol 109:168\u2013173","journal-title":"J Surg Oncol"},{"key":"1286_CR8","doi-asserted-by":"publisher","first-page":"16129","DOI":"10.1038\/srep16129","volume":"5","author":"Y Yu","year":"2015","unstructured":"Yu Y, Dong L, Li D, Chuai S, Wu Z, Zheng X, Cheng Y, Han L, Yu J, Gao M (2015) Targeted DNA sequencing detects mutations related to susceptibility among familial non-medullary thyroid cancer. Sci Rep 5:16129","journal-title":"Sci Rep"},{"key":"1286_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMoa1502449","volume":"373","author":"SK Gara","year":"2013","unstructured":"Gara SK, Jia L, Merino MJ, Agarwal SK, Zhang L, Cam M, Patel D, Kebebew E (2013) Germline HABP2 mutation causing familial nonmedullary thyroid cancer. N Engl J Med 373:448\u2013455","journal-title":"N Engl J Med"},{"key":"1286_CR10","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1210\/jc.2015-3928","volume":"10","author":"R Sahasrabudhe","year":"2016","unstructured":"Sahasrabudhe R, Stultz J, Williamson J, TCUKIN et al (2016) The HABP2 G534E variant is an unlikely cause of familial non-medullary thyroid cancer. J Clin Endocrinol Metab 10:1098\u20131103","journal-title":"J Clin Endocrinol Metab"},{"key":"1286_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1089\/thy.2015.0537","volume":"26","author":"AS Alzahrani","year":"2016","unstructured":"Alzahrani AS, Murugan AK, Qasem E, Al-Hindi H (2016) HABP2 Gene mutations do not cause familial or sporadic non-medullary thyroid cancer in a highly inbred middle eastern population. Thyroid 26:667\u2013671","journal-title":"Thyroid"},{"key":"1286_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12881-016-0323-1","volume":"17","author":"AL Weeks","year":"2016","unstructured":"Weeks AL, Wilson SG, Ward L, Goldblatt J, Hui J, Walsh JP (2016) HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer. BMC Med Genet 17:60","journal-title":"BMC Med Genet"},{"key":"1286_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1530\/ERC-16-0067","volume":"23","author":"S Peiling Yang","year":"2016","unstructured":"Peiling Yang S, Ngeow J (2016) Familial non-medullary thyroid cancer: unraveling the genetic maze. Endocr Relat Cancer 23:577\u2013595","journal-title":"Endocr Relat Cancer"},{"key":"1286_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2015","unstructured":"Haugen BR, Alexander EK, Bible KC et al (2015) (2016) American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26:1\u2013133","journal-title":"Thyroid"},{"key":"1286_CR15","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1002\/cncr.29038","volume":"120","author":"YE Nikiforov","year":"2014","unstructured":"Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN (2014) Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm\/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer 120:3627\u20133634","journal-title":"Cancer"},{"key":"1286_CR16","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/cncr.31245","volume":"124","author":"MN Nikiforova","year":"2018","unstructured":"Nikiforova MN, Mercurio S, Wald AI, Barbi de Moura M, Callenberg K, Santana-Santos L, Gooding WE, Yip L, Ferris RL, Nikiforov YE (2018) Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer 124:1682\u20131690","journal-title":"Cancer"},{"key":"1286_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"N Agrawal","year":"2014","unstructured":"Agrawal N, Akbani R, Aksoy BA, on behalf of Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676\u2013690","journal-title":"Cell"},{"key":"1286_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115\u2013132","journal-title":"CA Cancer J Clin"},{"key":"1286_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1089\/thy.2013.0045","volume":"23","author":"LG Morris","year":"2013","unstructured":"Morris LG, Sikora AG, Tosteson TD, Davies L (2013) The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23:885\u2013891","journal-title":"Thyroid"},{"key":"1286_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2009.1607","volume":"19","author":"MR Vriens","year":"2009","unstructured":"Vriens MR, Suh I, Moses W, Kebebew E (2009) Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 19:1343\u20131349","journal-title":"Thyroid"},{"key":"1286_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1089\/thy.2009.0216","volume":"20","author":"A Khan","year":"2010","unstructured":"Khan A, Smellie J, Nutting C, Harrington K, Newbold K (2010) Familial nonmedullary thyroid cancer: a review of the genetics. Thyroid 20:795\u2013801","journal-title":"Thyroid"},{"key":"1286_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg L, Hallstr\u00f6m BM, Oksvold P et al (2014) Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13:397\u2013406","journal-title":"Mol Cell Proteomics"},{"key":"1286_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ydbio.2014.04.019","volume":"392","author":"T Pradhan-Sundd","year":"2014","unstructured":"Pradhan-Sundd T, Verheyen EM (2014) The role of Bro1- domain-containing protein Myopic in endosomal trafficking of Wnt\/Wingless. Dev Biol 392:93\u2013107","journal-title":"Dev Biol"},{"key":"1286_CR24","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1073\/pnas.0801567105","volume":"105","author":"J McCullough","year":"2008","unstructured":"McCullough J, Fisher RD, Whitby FG, Sundquist WI, Hill CP (2008) ALIX-CHMP4 interactions in the human ESCRT pathway. Proc Natl Acad SciUSA 105:7687\u20137691","journal-title":"Proc Natl Acad SciUSA"},{"key":"1286_CR25","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.str.2012.03.001","volume":"20","author":"R Mu","year":"2012","unstructured":"Mu R, Dussupt V, Jiang J, Sette P, Rudd V, Chuenchor W, Bello NF, Bouamr F, Xiao TS (2012) Two distinct binding modes define the interaction of Brox with the C-terminal tails of CHMP5 and CHMP4B. Structure 20:887\u2013898","journal-title":"Structure"},{"key":"1286_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4161\/rna.20231","volume":"95","author":"E Matoulkova","year":"2012","unstructured":"Matoulkova E, Michalova E, Vojtesek B, Hrstka R (2012) The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol 95:563\u2013576","journal-title":"RNA Biol"},{"key":"1286_CR27","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1089\/thy.2016.0668","volume":"27","author":"J Klubo-Gwiezdzinska","year":"2017","unstructured":"Klubo-Gwiezdzinska J, Yang L, Merkel R, Patel D, Nilubol N, Merino MJ, Skarulis M, Sadowski SM, Kebebew E (2017) Results of screening in familial non-medullary thyroid cancer. Thyroid 27:1017\u20131024","journal-title":"Thyroid"},{"key":"1286_CR28","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1677\/ERC-08-0080","volume":"15","author":"M Capezzone","year":"2008","unstructured":"Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F (2008) Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075\u20131081","journal-title":"Endocr Relat Cancer"},{"key":"1286_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s40618-019-01039-0","volume":"42","author":"M Capezzone","year":"2019","unstructured":"Capezzone M, Secchi C, Fralassi N, Cantara S, Brilli L, Ciuoli C, Pilli T, Maino F, Forleo R, Pacini F, Castagna MG (2019) Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma? J Endocrinol Invest 42:1205\u20131213","journal-title":"J Endocrinol Invest"},{"key":"1286_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1530\/EJE-14-0960","volume":"172","author":"X Wang","year":"2015","unstructured":"Wang X, Cheng W, Li J, Su A, Wei T, Liu F, Zhu J (2015) Endocrine tumours: familial nonmedullary thyroid carcinoma is a more aggressive disease: a systematic review and meta-analysis. Eur J Endocrinol 172:253\u2013262","journal-title":"Eur J Endocrinol"},{"key":"1286_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/genes10070482","volume":"10","author":"K Hi\u0144cza","year":"2019","unstructured":"Hi\u0144cza K, Kowalik A, Kowalska A (2019) Current knowledge of germline genetic risk factors for the development of non-medullary thyroid cancer. Genes (basel) 10:482","journal-title":"Genes (basel)"},{"key":"1286_CR32","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/ijc.31825","volume":"144","author":"F Ye","year":"2019","unstructured":"Ye F, Gao H, Xiao L et al (2019) Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma. Int J Cancer 144:1321\u20131330","journal-title":"Int J Cancer"},{"key":"1286_CR33","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/ijc.32244","volume":"145","author":"V Cirello","year":"2019","unstructured":"Cirello V, Colombo C, Persani L, Fugazzola L (2019) Absence of the MAP2K5 germline variants c.G961A and c.T1100C in a wide series of familial nonmedullary thyroid carcinoma Italian families. Int J Cancer. 145:600","journal-title":"Int J Cancer."},{"key":"1286_CR34","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1089\/thy.2018.0736","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, Cheng W, Li J, Su A, Wei T, Liu F, Zhu J (2019) Identification of rare variants predisposing to thyroid cancer. Thyroid 29:946\u2013955","journal-title":"Thyroid"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01286-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01286-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01286-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T23:39:38Z","timestamp":1620430778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01286-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01286-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethical committee\u00a0of the Universit\u00e0 della Campania \u201cLuigi Vanvitelli\u201d protocol n\u00b054 del 2\/5\/2019 on Horizon 2020 Solve the Unsolved project.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The informed consent was obtained from the patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}